Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-22-000085
Filing Date
2022-01-11
Accepted
2022-01-11 16:06:00
Documents
2
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 zk2227042.html 3  
1 zk2227042.xml 3 4560
2 exhibit_24-1.htm EX-24.1 10085
  Complete submission text file 0001178913-22-000085.txt   16059
Mailing Address C/O ALLIANCE CAPITAL 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address
LIEBERMAN GERALD M (Reporting) CIK: 0001234346 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38556 | Film No.: 22523939

Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)